Abstract
The pituitary gland is a potential site for a range of pathologies, for which treatment can involve resection and/or ionizing radiation. Modern stereotactic radiosurgery (SRS) involves highly conformal radiation, allowing for the delivery of high doses to the tumor while simultaneously sparing nearby healthy structures. SRS has become a standard treatment option for residual or recurrent pituitary adenomas. It has been used for both functioning and nonfunctioning pituitary adenomas, with reported local tumor control over 90% and moderate rates of endocrine remission in functioning adenomas. We aim to briefly review the existing indictions and supporting literature for the use of SRS for refractory adenomas.
Original language | English (US) |
---|---|
Journal | Pituitary |
DOIs | |
State | Accepted/In press - 2023 |
Keywords
- Pituitary
- Pituitary adenoma
- Radiosurgery
- SRS
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Endocrinology